# Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI

> **NCT03252665** · PHASE4 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 600 (estimated)

## Conditions studied

- ST Segment Elevation Myocardial Infarction

## Interventions

- **DRUG:** Alprostadil
- **DRUG:** Nicorandil
- **DRUG:** Nitroglycerin

## Key facts

- **NCT ID:** NCT03252665
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2017-08-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03252665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03252665, "Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients Undergoing Primary PCI". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03252665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*